This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We read with interest the review of teleneurology by Hatcher-Martin et al.1 There have been limited studies about the use of teleneuroimmunology for antibody-mediated encephalitis.2 We provide some remote teleneuroimmunology experiences of KingMed Diagnostics (KMD), the largest independent medical laboratory in China.3 To date, the number of identified positive neuronal antibodies reached more than 4,500 by 2019 in KMD. One of the most important aspects of teleneuroimmunology in KMD is the close collaboration with consultant neuroimmunologists due to the potential increasing antibody-mediated encephalitis diagnostics service needs, particularly in low-resource areas with a shortage of specialists.4 Teleneuroimmunology focuses on counseling—i.e., providing second opinions on challenging cases—education, and reviewing diagnostic test results, conducting over 100 consultations each year. Teleneuroimmunology also seems to improve satisfaction between distant neurologists and the referral site, although quality control programs are limited. Potential challenges include lack of qualified physical examination and legal concerns. Together, our experiences may help in showing unique solutions in improving the diagnosis of rare diseases practice in China as well as in other developing countries.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
